Fmoc-AEEA-OH

Details:

Founded in December 2020, the company is committed to the process research and development and industrialization of pharmaceutical intermediates, chiral amino acids represented by D-penicillamine, and the process research and development and refining of raw materials represented by Tisirolimus. At the same time, our business scope also includes the development, production and sales of customized products. The company has well-equipped laboratories, modern analytical equipment, multi-functional kg laboratories and pilot production workshops. Relying on high quality and good customer service, we serve a wide range of pharmaceutical and biotechnology, agrochemical and specialty chemical companies around the world, covering FTE project research, small molecule compound synthesis, chemical process research and development, and production at different scales from kg to ton. At present, through independent research and development, the company has developed amino acid derivatives, a series of heterocyclic boric acid products and polypeptide pharmaceutical intermediates and other more than a dozen industrial products. The company adheres to the core values of "integrity, diligence, cooperation and innovation", and integrates a high-quality professional team of scientific research, management, production and marketing. The company's decision-making level is keen in thinking, advanced in consciousness, high in business quality, and rich in enterprise management experience. At present, the company has 9 R & D personnel, including 1 doctor and 2 master. We rely on technological innovation, actively build a modern enterprise management model, and strive to build the company into a first-class supplier of domestic pharmaceutical intermediates and fine chemical industry.